Wockhardt Ltd.

NSE: WOCKPHARMA | BSE: 532300 | ISIN: INE049B01025 | Industry: Pharmaceuticals
| Expensive Performer

1521.70
3.01%
HDFC Securities
Wockhardt Ltd Q3FY18 results comment Revenue decreased by 1.66% to Rs. 1005.3 Cr in Q3FY18 when compared to the previous quarter
Number of FII/FPI investors increased from 171 to 186 in Jun 2025 qtr.
More from Wockhardt Ltd.
Recommended